SAM Holdings    Last:0.035   -

SAM - IPO $0.23 Major SS Berjaya Grp

Made a history in SGX IPO.

Stocky901      ( Date: 26-Feb-2024 18:53) Posted: Everyday new low. Wonder when will it stop dropping..🥺 Newbornborn      ( Date: 26-Feb-2024 18:39) Posted: Laugeable and unbelievable drop price since IPO

 

Everyday new low. Wonder when will it stop dropping..🥺

Newbornborn      ( Date: 26-Feb-2024 18:39) Posted: Laugeable and unbelievable drop price since IPO. Stocky901      ( Date: 23-Feb-2024 10:31) Posted: Why this IPO no locking periods.. ? Really a joke 😔

 

Laugeable and unbelievable drop price since IPO.

Stocky901      ( Date: 23-Feb-2024 10:31) Posted: Why this IPO no locking periods.. ? Really a joke 😔 SmallSmall      ( Date: 23-Feb-2024 09:11) Posted: Now you know why this IPO $0.23 fared so badly. Clearbridge dumped 4 mil + from day 1. Their cost is $0.115. IPO dropped 50% in 4 days.  Expected a technical rebound because 2 insiders have bought shares from open market liao. DISPOSAL OF SHARES IN SINGAPORE INSTITUTE OF ADVANCED MEDICINE HOLDINGS LIMITED 1. BACKGROUND 1.1 Disposal of Shares in Singapore Institute of Advanced Medicine Holdings Limited The board of directors (" Board" or " Directors" ) of Clearbridge Health Limited (the " Company" and together with its subsidiaries, the " Group" ) wishes to announce that Clearbridge BSA Pte. Ltd. (" CBBSA" ), a wholly-owned subsidiary of the Company, has sold an aggregate of 4,397,500 ordinary shares in the capital of Singapore Institute of Advanced Medicine Holdings Limited (" SIAMH" ), representing approximately 0.44% of the issued and paid-up capital of SIAMH (the &ldquo Sale Shares&rdquo and ordinary shares of SIAMH, &ldquo SIAMH Shares&rdquo ), through a series of open market transactions of 3,381,000, 794,900 and 221,600 SIAMH Shares on 16, 19 and 20 February 2024, respectively (the " Disposal" ), at a volume weighted average sale price of S$0.184 per Sale Share. The aggregate consideration received by CBBSA in cash for the Disposal (after deducting brokerage, commission, applicable goods and services tax and other related expenses) is approximately S$806,000 (the " Consideration" ). Subsequent to the Disposal, CBBSA holds 3,102,500 SIAMH Shares (the &ldquo Remaining Shares&rdquo ), amounting to approximately 0.31% of the issued and paid-up capital of SIAMH as at the close of business on 20 February 2024

 

Why this IPO no locking periods.. ? Really a joke 😔

SmallSmall      ( Date: 23-Feb-2024 09:11) Posted: Now you know why this IPO $0.23 fared so badly. Clearbridge dumped 4 mil + from day 1. Their cost is $0.115. IPO dropped 50% in 4 days.  Expected a technical rebound because 2 insiders have bought shares from open market liao. DISPOSAL OF SHARES IN SINGAPORE INSTITUTE OF ADVANCED MEDICINE HOLDINGS LIMITED 1. BACKGROUND 1.1 Disposal of Shares in Singapore Institute of Advanced Medicine Holdings Limited The board of directors (" Board" or " Directors" ) of Clearbridge Health Limited (the " Company" and together with its subsidiaries, the " Group" ) wishes to announce that Clearbridge BSA Pte. Ltd. (" CBBSA" ), a wholly-owned subsidiary of the Company, has sold an aggregate of 4,397,500 ordinary shares in the capital of Singapore Institute of Advanced Medicine Holdings Limited (" SIAMH" ), representing approximately 0.44% of the issued and paid-up capital of SIAMH (the &ldquo Sale Shares&rdquo and ordinary shares of SIAMH, &ldquo SIAMH Shares&rdquo ), through a series of open market transactions of 3,381,000, 794,900 and 221,600 SIAMH Shares on 16, 19 and 20 February 2024, respectively (the " Disposal" ), at a volume weighted average sale price of S$0.184 per Sale Share. The aggregate consideration received by CBBSA in cash for the Disposal (after deducting brokerage, commission, applicable goods and services tax and other related expenses) is approximately S$806,000 (the " Consideration" ). Subsequent to the Disposal, CBBSA holds 3,102,500 SIAMH Shares (the &ldquo Remaining Shares&rdquo ), amounting to approximately 0.31% of the issued and paid-up capital of SIAMH as at the close of business on 20 February 2024

 

Now you know why this IPO $0.23 fared so badly.
Clearbridge dumped 4 mil + from day 1.
Their cost is $0.115.
IPO dropped 50% in 4 days. 
Expected a technical rebound because 2 insiders have bought shares from open market liao.



DISPOSAL OF SHARES IN SINGAPORE INSTITUTE OF ADVANCED MEDICINE HOLDINGS LIMITED

1. BACKGROUND 1.1 Disposal of Shares in Singapore Institute of Advanced Medicine Holdings Limited The board of directors (" Board" or " Directors" ) of Clearbridge Health Limited (the " Company" and together with its subsidiaries, the " Group" ) wishes to announce that Clearbridge BSA Pte. Ltd. (" CBBSA" ), a wholly-owned subsidiary of the Company, has sold an aggregate of 4,397,500 ordinary shares in the capital of Singapore Institute of Advanced Medicine Holdings Limited (" SIAMH" ), representing approximately 0.44% of the issued and paid-up capital of SIAMH (the &ldquo Sale Shares&rdquo and ordinary shares of SIAMH, &ldquo SIAMH Shares&rdquo ), through a series of open market transactions of 3,381,000, 794,900 and 221,600 SIAMH Shares on 16, 19 and 20 February 2024, respectively (the " Disposal" ), at a volume weighted average sale price of S$0.184 per Sale Share. The aggregate consideration received by CBBSA in cash for the Disposal (after deducting brokerage, commission, applicable goods and services tax and other related expenses) is approximately S$806,000 (the " Consideration" ). Subsequent to the Disposal, CBBSA holds 3,102,500 SIAMH Shares (the &ldquo Remaining Shares&rdquo ), amounting to approximately 0.31% of the issued and paid-up capital of SIAMH as at the close of business on 20 February 2024

 

Queue at $0.10 tikam tikam

Stocky901      ( Date: 21-Feb-2024 16:35) Posted: IPO oversubscribed.. now 0.135 Vs IPO price 0.230..🤨 🤨 Stocky901      ( Date: 19-Feb-2024 15:10) Posted: Nav only 10c +. IPO overpriced.. more rooms to drop..😕

 

Closed at 0.128. a real SGX joke..🤡 🤡

Stocky901      ( Date: 21-Feb-2024 16:35) Posted: IPO oversubscribed.. now 0.135 Vs IPO price 0.230..🤨 🤨 Stocky901      ( Date: 19-Feb-2024 15:10) Posted: Nav only 10c +. IPO overpriced.. more rooms to drop..😕

 

IPO oversubscribed.. now 0.135 Vs IPO price 0.230..🤨 🤨

Stocky901      ( Date: 19-Feb-2024 15:10) Posted: Nav only 10c +. IPO overpriced.. more rooms to drop..😕 huattuatua      ( Date: 16-Feb-2024 10:34) Posted: when u read their prospectus, its been making losses for very long already, how to invest

 

Nav only 10c +. IPO overpriced.. more rooms to drop..😕

huattuatua      ( Date: 16-Feb-2024 10:34) Posted: when u read their prospectus, its been making losses for very long already, how to invest? SmallSmall      ( Date: 16-Feb-2024 10:21) Posted: Should at least go nearer to $0.20 lah....quite shameful for SG

 

when u read their prospectus, its been making losses for very long already, how to invest?

SmallSmall      ( Date: 16-Feb-2024 10:21) Posted: Should at least go nearer to $0.20 lah....quite shameful for SGX SmallSmall      ( Date: 16-Feb-2024 10:19) Posted: IPO Price $0.23. Now $0.19 First day.... Part of Berjaya Group Malaysia. For Immediate Release Singapore Institute of Advanced Medicine Holdings Ltd&rsquo s IPO garners strong support from investors  Placement Shares under the Invitation were fully subscribed for  Public Offer Shares was approximately 1.39 times subscribed  Gross proceeds of approximately S$26.2 million raised through the Invitation  Trading of SAM Holdings&rsquo shares to commence at 9:00 a.m. (Singapore Time) on 16 February 2024 under the ticker &ldquo 9G2&rdquo on the Catalist Board of the SGXST Singapore, 15 February 2024 &ndash Singapore Institute of Advanced Medicine Holdings Ltd. (&ldquo SAM Holdings&rdquo or the &ldquo Company&rdquo , and together with its subsidiaries, the &ldquo Group&rdquo ), which aims to become a comprehensive one-stop ambulatory cancer centre, is pleased to announce that it has received strong support for its initial public offering (&ldquo IPO&rdquo ) and its Invitation Shares are fully subscribed. Following the close of the Application List in Singapore at 12.00 noon (Singapore time) on 14 February 2024, the Board of Directors of the Company (the &ldquo Board&rdquo ) is pleased to announce the following: The Placement was fully subscribed for. As at the close of the Application List in Singapore at 12.00 noon (Singapore time) on 14 February 2024, there were 286 valid applications made by way of Application Forms or Electronic Applications for an aggregate of 6,141,000 Public Offer Shares. Based on the 4,415,000 Invitation Shares available to the public for subscription, the Public Offer was approximately 1.39 times subscribed. Based on the aggregate number of 114,000,000 Invitation Shares under the Invitation, the valid applications received under the Public Offer as at the close of the Invitation and the aggregate valid applications received under the Placement, the Invitation was approximately 1.01 times subscribed. Taking into consideration the valid applications for the Invitation Shares, PrimePartners Corporate Finance Pte. Ltd., the Sponsor, Issue Manager, Underwriter and Placement Agent, in consultation with the Company, has decided that the aggregate number of 114,000,000 Invitation Shares will be re-allocated as follows: Page 2 of 4 Singapore Institute of Advanced Medicine Holdings Ltd.    1 Biopolis Drive #02‐ 01 Amnios Singapore 138622  109,126,000 Invitation Shares pursuant to the Placement and  4,874,000 Invitation Shares pursuant to the Public Offer. Trading of SAM Holdings&rsquo shares is expected to commence at 9.00 a.m. (Singapore time) on 16 February 2024, subject to the SGX-ST being satisfied that all conditions necessary for commencement of trading in the Shares on a &ldquo ready&rdquo basis have been fulfilled. Dr Djeng Shih Kien, the Executive Director and CEO, and founder of SAM Holdings, said, &ldquo As we embark on this journey, fueled by the success of our IPO, we believe that our subscription is not just a testament to our past achievements, but a vote of confidence for the growth and impact yet to come. We aim to help our patients achieve better outcomes and better quality of life. The team is excited for a future where innovation, compassion, and collaboration converge in this fight against cancer.&rdquo The Board wishes to thank all applicants who have applied for the Invitation Shares, the relevant authorities and all who have helped in one way or another in the Company&rsquo s IPO, for their support and assistance.

 

Should at least go nearer to $0.20 lah....quite shameful for SGX

SmallSmall      ( Date: 16-Feb-2024 10:19) Posted: IPO Price $0.23. Now $0.19 First day.... Part of Berjaya Group Malaysia. For Immediate Release Singapore Institute of Advanced Medicine Holdings Ltd&rsquo s IPO garners strong support from investors  Placement Shares under the Invitation were fully subscribed for  Public Offer Shares was approximately 1.39 times subscribed  Gross proceeds of approximately S$26.2 million raised through the Invitation  Trading of SAM Holdings&rsquo shares to commence at 9:00 a.m. (Singapore Time) on 16 February 2024 under the ticker &ldquo 9G2&rdquo on the Catalist Board of the SGXST Singapore, 15 February 2024 &ndash Singapore Institute of Advanced Medicine Holdings Ltd. (&ldquo SAM Holdings&rdquo or the &ldquo Company&rdquo , and together with its subsidiaries, the &ldquo Group&rdquo ), which aims to become a comprehensive one-stop ambulatory cancer centre, is pleased to announce that it has received strong support for its initial public offering (&ldquo IPO&rdquo ) and its Invitation Shares are fully subscribed. Following the close of the Application List in Singapore at 12.00 noon (Singapore time) on 14 February 2024, the Board of Directors of the Company (the &ldquo Board&rdquo ) is pleased to announce the following: The Placement was fully subscribed for. As at the close of the Application List in Singapore at 12.00 noon (Singapore time) on 14 February 2024, there were 286 valid applications made by way of Application Forms or Electronic Applications for an aggregate of 6,141,000 Public Offer Shares. Based on the 4,415,000 Invitation Shares available to the public for subscription, the Public Offer was approximately 1.39 times subscribed. Based on the aggregate number of 114,000,000 Invitation Shares under the Invitation, the valid applications received under the Public Offer as at the close of the Invitation and the aggregate valid applications received under the Placement, the Invitation was approximately 1.01 times subscribed. Taking into consideration the valid applications for the Invitation Shares, PrimePartners Corporate Finance Pte. Ltd., the Sponsor, Issue Manager, Underwriter and Placement Agent, in consultation with the Company, has decided that the aggregate number of 114,000,000 Invitation Shares will be re-allocated as follows: Page 2 of 4 Singapore Institute of Advanced Medicine Holdings Ltd.    1 Biopolis Drive #02‐ 01 Amnios Singapore 138622  109,126,000 Invitation Shares pursuant to the Placement and  4,874,000 Invitation Shares pursuant to the Public Offer. Trading of SAM Holdings&rsquo shares is expected to commence at 9.00 a.m. (Singapore time) on 16 February 2024, subject to the SGX-ST being satisfied that all conditions necessary for commencement of trading in the Shares on a &ldquo ready&rdquo basis have been fulfilled. Dr Djeng Shih Kien, the Executive Director and CEO, and founder of SAM Holdings, said, &ldquo As we embark on this journey, fueled by the success of our IPO, we believe that our subscription is not just a testament to our past achievements, but a vote of confidence for the growth and impact yet to come. We aim to help our patients achieve better outcomes and better quality of life. The team is excited for a future where innovation, compassion, and collaboration converge in this fight against cancer.&rdquo The Board wishes to thank all applicants who have applied for the Invitation Shares, the relevant authorities and all who have helped in one way or another in the Company&rsquo s IPO, for their support and assistance.

 

IPO Price $0.23. Now $0.19 First day.... Part of Berjaya Group Malaysia.

For Immediate Release Singapore Institute of Advanced Medicine Holdings Ltd&rsquo s IPO garners strong support from investors

 Placement Shares under the Invitation were fully subscribed for  Public Offer Shares was approximately 1.39 times subscribed  Gross proceeds of approximately S$26.2 million raised through the Invitation
 Trading of SAM Holdings&rsquo shares to commence at 9:00 a.m. (Singapore Time) on 16 February 2024 under the ticker &ldquo 9G2&rdquo on the Catalist Board of the SGXST Singapore, 15 February 2024 &ndash Singapore Institute of Advanced Medicine Holdings Ltd. (&ldquo SAM Holdings&rdquo or the &ldquo Company&rdquo , and together with its subsidiaries, the &ldquo Group&rdquo ), which aims to become a comprehensive one-stop ambulatory cancer centre, is pleased to announce that it has received strong support for its initial public offering (&ldquo IPO&rdquo ) and its Invitation Shares are fully subscribed. Following the close of the Application List in Singapore at 12.00 noon (Singapore time) on 14 February 2024, the Board of Directors of the Company (the &ldquo Board&rdquo ) is pleased to announce the following: The Placement was fully subscribed for. As at the close of the Application List in Singapore at 12.00 noon (Singapore time) on 14 February 2024, there were 286 valid applications made by way of Application Forms or Electronic Applications for an aggregate of 6,141,000 Public Offer Shares. Based on the 4,415,000 Invitation Shares available to the public for subscription, the Public Offer was approximately 1.39 times subscribed. Based on the aggregate number of 114,000,000 Invitation Shares under the Invitation, the valid applications received under the Public Offer as at the close of the Invitation and the aggregate valid applications received under the Placement, the Invitation was approximately 1.01 times subscribed. Taking into consideration the valid applications for the Invitation Shares, PrimePartners Corporate Finance Pte. Ltd., the Sponsor, Issue Manager, Underwriter and Placement Agent, in consultation with the Company, has decided that the aggregate number of 114,000,000 Invitation Shares will be re-allocated as follows: Page 2 of 4 Singapore Institute of Advanced Medicine Holdings Ltd.    1 Biopolis Drive #02‐ 01 Amnios Singapore 138622
 109,126,000 Invitation Shares pursuant to the Placement and  4,874,000 Invitation Shares pursuant to the Public Offer. Trading of SAM Holdings&rsquo shares is expected to commence at 9.00 a.m. (Singapore time) on 16 February 2024, subject to the SGX-ST being satisfied that all conditions necessary for commencement of trading in the Shares on a &ldquo ready&rdquo basis have been fulfilled. Dr Djeng Shih Kien, the Executive Director and CEO, and founder of SAM Holdings, said, &ldquo As we embark on this journey, fueled by the success of our IPO, we believe that our subscription is not just a testament to our past achievements, but a vote of confidence for the growth and impact yet to come. We aim to help our patients achieve better outcomes and better quality of life. The team is excited for a future where innovation, compassion, and collaboration converge in this fight against cancer.&rdquo The Board wishes to thank all applicants who have applied for the Invitation Shares, the relevant authorities and all who have helped in one way or another in the Company&rsquo s IPO, for their support and assistance.